BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

340 related articles for article (PubMed ID: 12885345)

  • 1. Improved packaging system for generation of high-level noncytotoxic HSV-1 amplicon vectors using Cre-loxP site-specific recombination to delete the packaging signals of defective helper genomes.
    Zaupa C; Revol-Guyot V; Epstein AL
    Hum Gene Ther; 2003 Jul; 14(11):1049-63. PubMed ID: 12885345
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A novel approach for herpes simplex virus type 1 amplicon vector production, using the Cre-loxP recombination system to remove helper virus.
    Logvinoff C; Epstein AL
    Hum Gene Ther; 2001 Jan; 12(2):161-7. PubMed ID: 11177553
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combined HSV-1 recombinant and amplicon piggyback vectors: replication-competent and defective forms, and therapeutic efficacy for experimental gliomas.
    Pechan PA; Herrlinger U; Aghi M; Jacobs A; Breakefield XO
    J Gene Med; 1999; 1(3):176-85. PubMed ID: 10738566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C
    Curr Protoc Hum Genet; 2002 Aug; Chapter 12():Unit 12.12. PubMed ID: 18428323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved helper virus-free packaging system for HSV amplicon vectors using an ICP27-deleted, oversized HSV-1 DNA in a bacterial artificial chromosome.
    Saeki Y; Fraefel C; Ichikawa T; Breakefield XO; Chiocca EA
    Mol Ther; 2001 Apr; 3(4):591-601. PubMed ID: 11319922
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Fraefel C
    Curr Protoc Neurosci; 2007 Jul; Chapter 4():Unit 4.14. PubMed ID: 18428655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genetic engineering of herpes simplex virus and vector genomes carrying loxP sites in cells expressing Cre recombinase.
    Logvinoff C; Epstein AL
    Virology; 2000 Feb; 267(1):102-10. PubMed ID: 10648187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Gene delivery using helper virus-free HSV-1 amplicon vectors.
    Laimbacher AS; Fraefel C
    Curr Protoc Neurosci; 2012 Jul; Chapter 4():Unit 4.14. PubMed ID: 22752894
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Herpes simplex virus type 1 DNA amplified as bacterial artificial chromosome in Escherichia coli: rescue of replication-competent virus progeny and packaging of amplicon vectors.
    Saeki Y; Ichikawa T; Saeki A; Chiocca EA; Tobler K; Ackermann M; Breakefield XO; Fraefel C
    Hum Gene Ther; 1998 Dec; 9(18):2787-94. PubMed ID: 9874276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased transcomplementation properties of plasmids carrying HSV-1 origin of replication and packaging signals.
    Berthomme H; Fournel S; Epstein AL
    Virology; 1996 Feb; 216(2):437-43. PubMed ID: 8607275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Generation of high-titer defective HSV-1 vectors.
    Lim F; Neve RL
    Curr Protoc Neurosci; 2001 May; Chapter 4():Unit 4.13. PubMed ID: 18428477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An enhanced packaging system for helper-dependent herpes simplex virus vectors.
    Stavropoulos TA; Strathdee CA
    J Virol; 1998 Sep; 72(9):7137-43. PubMed ID: 9696807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of vhs and VP16 during HSV-1 helper virus-free amplicon packaging enhances titers.
    Bowers WJ; Howard DF; Brooks AI; Halterman MW; Federoff HJ
    Gene Ther; 2001 Jan; 8(2):111-20. PubMed ID: 11313780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Improved HSV-1 amplicon packaging system using ICP27-deleted, oversized HSV-1 BAC DNA.
    Saeki Y; Breakefield XO; Chiocca EA
    Methods Mol Med; 2003; 76():51-60. PubMed ID: 12526158
    [No Abstract]   [Full Text] [Related]  

  • 15. An HSV-1 amplicon system for prostate-specific expression of ICP4 to complement oncolytic viral replication for in vitro and in vivo treatment of prostate cancer cells.
    Lee CY; Bu LX; Rennie PS; Jia WW
    Cancer Gene Ther; 2007 Jul; 14(7):652-60. PubMed ID: 17479106
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gutted adenoviral vector growth using E1/E2b/E3-deleted helper viruses.
    Barjot C; Hartigan-O'Connor D; Salvatori G; Scott JM; Chamberlain JS
    J Gene Med; 2002; 4(5):480-9. PubMed ID: 12221641
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development of a FLP/frt system for generating helper-dependent adenoviral vectors.
    Ng P; Beauchamp C; Evelegh C; Parks R; Graham FL
    Mol Ther; 2001 May; 3(5 Pt 1):809-15. PubMed ID: 11356086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of high-titer defective HSV-1 vectors using an IE 2 deletion mutant and quantitative study of expression in cultured cortical cells.
    Lim F; Hartley D; Starr P; Lang P; Song S; Yu L; Wang Y; Geller AI
    Biotechniques; 1996 Mar; 20(3):460-9. PubMed ID: 8679207
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intracellular Cre-mediated deletion of the unique packaging signal carried by a herpes simplex virus type 1 recombinant and its relationship to the cleavage-packaging process.
    Logvinoff C; Epstein AL
    J Virol; 2000 Sep; 74(18):8402-12. PubMed ID: 10954540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors.
    Saydam O; Glauser DL; Fraefel C
    Cold Spring Harb Protoc; 2012 Mar; 2012(3):352-6. PubMed ID: 22383640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.